Alan L. Kaplan
Papers
2
Total Citations
155
H-Index
2
About
Alan L. Kaplan is a leading urologic oncologist whose research focuses on improving the value of cancer care through cost analysis and health services innovation. His most influential work applies time-driven activity-based costing (TDABC) to quantify the true short- and long-term costs of treating localized, low-risk prostate cancer—a study that has garnered 144 citations and reshaped how clinicians and administrators evaluate treatment trade-offs. Kaplan’s contributions extend to leveraging natural language processing (NLP) to automate case identification for radical cystectomy patients, demonstrating how electronic health record data can enhance quality measurement and surgical outcomes research. With a career dedicated to marrying clinical expertise with operational efficiency, his work provides a rigorous framework for understanding resource allocation in oncology. Kaplan’s research not only informs evidence-based decision-making for patients and providers but also sets a benchmark for cost transparency in urologic care. His pioneering use of TDABC and NLP marks him as a key figure in the movement toward high-value, data-driven healthcare delivery.
Research Focus
Key Achievements
Top Papers
- 1
- 2